Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Advantages of Ulipristal Acetate for the Preoperative Treatment of Hypoechoic Cellular Leiomyomas

NCT02361905 is registered in ClinicalTrials.gov with University Magna Graecia as lead sponsor.

NCT NCT02361905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02361905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Advantages of Ulipristal Acetate for the Preoperative Treatment of Hypoechoic Cellular Leiomyomas
Lead sponsor
University Magna Graecia
Phase
Phase 4
Overall status
Unknown status
Start date
February 28, 2015
Completion date
September 30, 2017
Enrollment
42 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibroid